Shannon P Fortin Ensign (Shannon Fortin Ensign)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

Current treatment options in oncology

International journal of molecular sciences

Clinical Medicine Insights. Oncology

Neuro-oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Mylan R Blomquist, Ryan Eghlimi, Angad Beniwal, Dustin Grief, David G Nascari, Landon Inge, Christopher P Sereduk, Serdar Tuncali, Alison Roos, Hannah Inforzato, Ritin Sharma, Patrick Pirrotte, Shwetal Mehta, Shannon P Fortin Ensign, Joseph C Loftus, Nhan L Tran
EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma. International journal of molecular sciences 25 (11) (2024)
Mylan R Blomquist, Ryan Eghlimi, Angad Beniwal, Dustin Grief, David G Nascari, Landon Inge, Christopher P Sereduk, Serdar Tuncali, Alison Roos, Hannah Inforzato, Ritin Sharma, Patrick Pirrotte, Shwetal Mehta, Shannon P Fortin Ensign, Joseph C Loftus, Nhan L Tran
EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma. International journal of molecular sciences 25 (11) (2024)
Mylan R Blomquist, Ryan Eghlimi, Angad Beniwal, Dustin Grief, David G Nascari, Landon Inge, Christopher P Sereduk, Serdar Tuncali, Alison Roos, Hannah Inforzato, Ritin Sharma, Patrick Pirrotte, Shwetal Mehta, Shannon P Fortin Ensign, Joseph C Loftus, Nhan L Tran
EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma. International journal of molecular sciences 25 (11) (2024)
Holly M Thomson, Shannon P Fortin Ensign, Victoria S Edmonds, Akanksha Sharma, Richard J Butterfield, Steven E Schild, Jonathan B Ashman, Richard S Zimmerman, Naresh P Patel, Alan H Bryce, Sujay A Vora, Terence T Sio, Alyx B Porter
Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma. Clinical Medicine Insights. Oncology 17 (2023)
Holly M Thomson, Shannon P Fortin Ensign, Victoria S Edmonds, Akanksha Sharma, Richard J Butterfield, Steven E Schild, Jonathan B Ashman, Richard S Zimmerman, Naresh P Patel, Alan H Bryce, Sujay A Vora, Terence T Sio, Alyx B Porter
Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma. Clinical Medicine Insights. Oncology 17 (2023)
Shannon P Fortin Ensign, Charles Gaulin, Maya Hrachova, Michael Ruff, Ehab Harahsheh, Kevin Vicenti, Januario Castro, Javier Munoz, Allison Rosenthal, Maciej M Mrugala
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy. Current treatment options in oncology 23 (12) (2022)
Shannon P Fortin Ensign, Charles Gaulin, Maya Hrachova, Michael Ruff, Ehab Harahsheh, Kevin Vicenti, Januario Castro, Javier Munoz, Allison Rosenthal, Maciej M Mrugala
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy. Current treatment options in oncology 23 (12) (2022)
Shannon P Fortin Ensign, Charles Gaulin, Maya Hrachova, Michael Ruff, Ehab Harahsheh, Kevin Vicenti, Januario Castro, Javier Munoz, Allison Rosenthal, Maciej M Mrugala
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy. Current treatment options in oncology (2022)
Shannon P Fortin Ensign, Charles Gaulin, Maya Hrachova, Michael Ruff, Ehab Harahsheh, Kevin Vicenti, Januario Castro, Javier Munoz, Allison Rosenthal, Maciej M Mrugala
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy. Current treatment options in oncology 23 (12) (2022)
Shannon P Fortin Ensign, Charles Gaulin, Maya Hrachova, Michael Ruff, Ehab Harahsheh, Kevin Vicenti, Januario Castro, Javier Munoz, Allison Rosenthal, Maciej M Mrugala
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy. Current treatment options in oncology 23 (12) (2022)
Shannon P Fortin Ensign, Maya Hrachova, Susan Chang, Maciej M Mrugala
Assessing the utility and attitudes toward molecular testing in neuro-oncology: a survey of the Society for Neuro-Oncology members. Neuro-oncology practice 8 (3) (2021)
Shannon P Fortin Ensign, Kathryn Bollin, Sherri Z Millis, Brian R Hinds, Michael Kosty, Christopher Uchiyama
Genomic analysis reveals low tumor mutation burden which may be associated with GNAQ/11 alteration in a series of primary leptomeningeal melanomas. Pigment cell & melanoma research 33 (3) (2019)

Shannon P Fortin Ensign.css-eqlu8i{font-size:small;padding-left:4px;} (Shannon Fortin Ensign)

Publication Activity (10 Years)

Top Topics

Top Venues

Shannon P Fortin Ensign (Shannon Fortin Ensign)